PCORI Board approves $94 million in new research awards, green-lights new funding opportunities
Our Board of Governors approved more than $94 million to fund 13 new comparative clinical effectiveness research (CER) studies at its meeting in Washington, D.C., on Monday, April 30. The funds will support studies on a range of conditions, including childhood obesity and chronic low back pain. The total also includes $10 million for two studies that will focus on medication-assisted treatment for pregnant women with opioid use disorder and $20 million for four awards that will use PCORnet, National Patient-Centered Clinical Research Network, to conduct CER.
In addition, the Board approved the development of two new PCORI Funding Announcements (PFAs). One will seek study proposals to understand if psychosocial interventions are more effective than usual care for patients who receive office-based opioid treatment with buprenorphine. The other PFA will complement existing dissemination and implementation efforts. It will support projects that facilitate the uptake of peer-reviewed CER results from our major research investments, such as pragmatic clinical studies and PCORnet demonstration studies.
To learn more from the Board of Governors Meeting.